Ryan Arthur (Affiliate) plans to sell 300 REGN shares, about $283,683

Form: 144
Filed: Feb 1, 2024, 4:47 pm ET
Importance: Routine
Accession: 0001968582-24-000073

Approximate sale date: Feb 1, 2024
Broker: J.P. Morgan Securities LLC
Shares acquired by: Stock award
10b5-1 plan adopted: Aug 7, 2023

All of Ryan Arthur's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

Sold 6 shares at $941.91 on Feb 1, 2024 · Form 4
Sold 5 shares at $942.5 on Feb 1, 2024 · Form 4
Sold 3 shares at $943.54 on Feb 1, 2024 · Form 4
Sold 3 shares at $947.37 on Feb 1, 2024 · Form 4
Sold 10 shares at $949.48 on Feb 1, 2024 · Form 4
Sold 2 shares at $950.01 on Feb 1, 2024 · Form 4
Sold 3 shares at $951.4 on Feb 1, 2024 · Form 4
Sold 3 shares at $953.18 on Feb 1, 2024 · Form 4
Sold 5 shares at $954.52 on Feb 1, 2024 · Form 4
Sold 10 shares at $955.35 on Feb 1, 2024 · Form 4
Sold 7 shares at $956.21 on Feb 1, 2024 · Form 4
Sold 3 shares at $957.75 on Feb 1, 2024 · Form 4
Sold 5 shares at $958.65 on Feb 1, 2024 · Form 4
Sold 8 shares at $959.68 on Feb 1, 2024 · Form 4
Sold 10 shares at $960.52 on Feb 1, 2024 · Form 4
Sold 4 shares at $961.37 on Feb 1, 2024 · Form 4
Sold 6 shares at $962.49 on Feb 1, 2024 · Form 4
Sold 4 shares at $963.73 on Feb 1, 2024 · Form 4
Sold 1 shares at $967.5 on Mar 1, 2024 · Form 4
Sold 1 shares at $968.66 on Mar 1, 2024 · Form 4
Sold 1 shares at $969.18 on Mar 1, 2024 · Form 4
Sold 4 shares at $970.38 on Mar 1, 2024 · Form 4
Sold 1 shares at $971.75 on Mar 1, 2024 · Form 4
Sold 2 shares at $972.29 on Mar 1, 2024 · Form 4
Sold 1 shares at $974.78 on Mar 1, 2024 · Form 4
Sold 2 shares at $975.7 on Mar 1, 2024 · Form 4
Sold 2 shares at $976.81 on Mar 1, 2024 · Form 4
Sold 2 shares at $977.27 on Mar 1, 2024 · Form 4
Sold 1 shares at $978.09 on Mar 1, 2024 · Form 4
Sold 1 shares at $979.87 on Mar 1, 2024 · Form 4
Sold 1 shares at $980.21 on Mar 1, 2024 · Form 4
Sold 15 shares at $981.64 on Mar 1, 2024 · Form 4
Sold 11 shares at $982.67 on Mar 1, 2024 · Form 4
Sold 12 shares at $983.61 on Mar 1, 2024 · Form 4
Sold 19 shares at $984.45 on Mar 1, 2024 · Form 4
Sold 10 shares at $985.76 on Mar 1, 2024 · Form 4
Sold 8 shares at $986.58 on Mar 1, 2024 · Form 4
Sold 4 shares at $987.33 on Mar 1, 2024 · Form 4
Sold 1 shares at $988.3 on Mar 1, 2024 · Form 4
Sold 2 shares at $957.78 on Apr 1, 2024 · Form 4
Sold 2 shares at $958.86 on Apr 1, 2024 · Form 4
Sold 9 shares at $959.47 on Apr 1, 2024 · Form 4
Sold 15 shares at $960.53 on Apr 1, 2024 · Form 4
Sold 14 shares at $961.59 on Apr 1, 2024 · Form 4
Sold 9 shares at $962.42 on Apr 1, 2024 · Form 4
Sold 20 shares at $963.6 on Apr 1, 2024 · Form 4
Sold 16 shares at $964.45 on Apr 1, 2024 · Form 4
Sold 13 shares at $965.35 on Apr 1, 2024 · Form 4
Sold 3 shares at $889.5 on May 1, 2024 · Form 4
Sold 2 shares at $890.75 on May 1, 2024 · Form 4
Sold 1 shares at $902.66 on May 1, 2024 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the app Get the app View on EDGAR

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

Zoetis ZTS public float $69.2B, Jun 30, 2025
Idexx Laboratories IDXX public float $42.9B, Jun 30, 2025
Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025
Bristol Myers Squibb BMY public float $94.2B, Jun 30, 2025
Gilead Sciences GILD public float $103.2B, Jun 30, 2025

Get an email when Regeneron Pharmaceuticals files

Similar companies